Klaus Martin Kortüm (Martin Kortüm, K M Kortuem, K Martin Kortüm, K Martin Kortüm, Martin K Kortüm)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 51

Top Venues

Leukemia

Communications biology

Cancers

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Dominik Schmidt, Viktor Fetsch, Alexander Zähringer, Henrike Salié, Dimitrios Athanassopoulos, Lukas M Braun, Nora R Javorniczky, Jenny N H G Ho, Katrin Kierdorf, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian M Capitini, Terry J Fry, Thomas Blank, Bruce R Blazar, Eva Maria Wagner-Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp T Meyer, Joachim Brumberg, Simon Völkl, Andreas Mackensen, Roland Coras, Michael von Bergwelt-Baildon, Nathalie L Albert, Laura M Bartos, Matthias Brendel, Adrien Holzgreve, Matthias Mack, Melanie Börries, Crystal L Mackall, Justus Duyster, Philipp Henneke, Josef Priller, Natalie Stickel, Felix L Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nature cancer (2024)
Mara John, Moutaz Helal, Johannes Duell, Greta Mattavelli, Emilia Stanojkovska, Nazia Afrin, Alexander Michael Leipold, Maximilian Johannes Steinhardt, Xiang Zhou, David Žihala, Anjana Anilkumar Sithara, Julia Mersi, Johannes M Waldschmidt, Christine Riedhammer, Sofie-Katrin Kadel, Marietta Truger, Rudolf A Werner, Claudia Haferlach, Hermann Einsele, Kai Kretzschmar, Tomas Jelinek, Andreas Rosenwald, Klaus Martin Kortüm, Angela Riedel, Leo Rasche
Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma. Blood (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Dominik Schmidt, Viktor Fetsch, Alexander Zähringer, Henrike Salié, Dimitrios Athanassopoulos, Lukas M Braun, Nora R Javorniczky, Jenny N H G Ho, Katrin Kierdorf, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian M Capitini, Terry J Fry, Thomas Blank, Bruce R Blazar, Eva Maria Wagner-Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp T Meyer, Joachim Brumberg, Simon Völkl, Andreas Mackensen, Roland Coras, Michael von Bergwelt-Baildon, Nathalie L Albert, Laura M Bartos, Matthias Brendel, Adrien Holzgreve, Matthias Mack, Melanie Börries, Crystal L Mackall, Justus Duyster, Philipp Henneke, Josef Priller, Natalie Stickel, Felix L Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nature cancer 5 (8) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Dominik Schmidt, Viktor Fetsch, Alexander Zähringer, Henrike Salié, Dimitrios Athanassopoulos, Lukas M Braun, Nora R Javorniczky, Jenny N H G Ho, Katrin Kierdorf, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian M Capitini, Terry J Fry, Thomas Blank, Bruce R Blazar, Eva Maria Wagner-Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp T Meyer, Joachim Brumberg, Simon Völkl, Andreas Mackensen, Roland Coras, Michael von Bergwelt-Baildon, Nathalie L Albert, Laura M Bartos, Matthias Brendel, Adrien Holzgreve, Matthias Mack, Melanie Börries, Crystal L Mackall, Justus Duyster, Philipp Henneke, Josef Priller, Natalie Stickel, Felix L Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nature cancer 5 (8) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
Xiang Zhou, Vivien Wagner, Lukas Scheller, Emilia Stanojkovska, Christine Riedhammer, Xianghui Xiao, Maximilian Johannes Steinhardt, Cornelia Vogt, Silvia Nerreter, Florian Eisele, Mara John, Umair Munawar, Sofie-Katrin Kadel, Julia Mersi, Anna Ruckdeschel, Sven Schimanski, Larissa Haertle, Johannes Moritz Waldschmidt, Seungbin Han, Max Topp, Johannes Duell, Hermann Einsele, Angela Riedel, Klaus Martin Kortüm, Leo Rasche
Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study. British journal of haematology (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Dominik Schmidt, Viktor Fetsch, Alexander Zähringer, Henrike Salié, Dimitrios Athanassopoulos, Lukas M Braun, Nora R Javorniczky, Jenny N H G Ho, Katrin Kierdorf, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian M Capitini, Terry J Fry, Thomas Blank, Bruce R Blazar, Eva Maria Wagner-Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp T Meyer, Joachim Brumberg, Simon Völkl, Andreas Mackensen, Roland Coras, Michael von Bergwelt-Baildon, Nathalie L Albert, Laura M Bartos, Matthias Brendel, Adrien Holzgreve, Matthias Mack, Melanie Börries, Crystal L Mackall, Justus Duyster, Philipp Henneke, Josef Priller, Natalie Stickel, Felix L Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nature cancer (2024)
Maximilian Johannes Steinhardt, Vladimir Cejka, Mengmeng Chen, Sabrina Bäuerlein, Julia Schäfer, Ali Adrah, Sandra M Ihne-Schubert, Aikaterini Papagianni, Klaus Martin Kortüm, Caroline Morbach, Stefan Stoerk
Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis-A Clinical Feasibility Study. Journal of clinical medicine 13 (1) (2024)
Maximilian Johannes Steinhardt, Vladimir Cejka, Mengmeng Chen, Sabrina Bäuerlein, Julia Schäfer, Ali Adrah, Sandra M Ihne-Schubert, Aikaterini Papagianni, Klaus Martin Kortüm, Caroline Morbach, Stefan Stoerk
Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis-A Clinical Feasibility Study. Journal of clinical medicine 13 (1) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M Poos, Britta Besemer, Kaya Miah, Axel Benner, Nicole Becker, Thomas Moehler, Ivana Metzler, Cyrus Khandanpour, Andrea Seidel-Glaetzer, Karolin Trautmann-Grill, Klaus Martin Kortüm, Carsten Muller-Tidow, Gunhild Mechtersheimer, Benjamin Goeppert, Albrecht Stenzinger, Niels Weinhold, Hartmut Goldschmidt, Katja C Weisel, Marc S Raab
A phase II clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma. Blood (2023)
Alexandra M Poos, Nina Prokoph, Moritz Jakob Przybilla, Jan-Philipp Mallm, Simon Steiger, Isabelle Seufert, Lukas John, Stephan M Tirier, Katharina Bauer, Anja Baumann, Jennifer Rohleder, Umair Munawar, Leo Rasche, Klaus Martin Kortüm, Nicola Giesen, Philipp Reichert, Stefanie Huhn, Carsten Muller-Tidow, Hartmut Goldschmidt, Oliver Stegle, Marc S Raab, Karsten Rippe, Niels Weinhold
Resolving therapy resistance mechanisms in multiple myeloma by multi-omics subclone analysis. Blood (2023)
Holly Lee, Sungwoo Ahn, Ranjan Maity, Noemie Leblay, Bachisio Ziccheddu, Marietta Truger, Monika Chojnacka, Anthony Cirrincione, Michael A Durante, Remi Tilmont, Elie Barakat, Mansour Poorebrahim, Sarthak Sinha, John McIntyre, Angela M Y Chan, Holly Wilson, Shari Kyman, Amrita Krishnan, Carl Ola Landgren, Wencke Walter, Manja Meggendorfer, Claudia Haferlach, Torsten Haferlach, Hermann Einsele, Klaus Martin Kortüm, Stefan Knop, Jean Baptiste Alberge, Andreas Rosenwald, Jonathan J Keats, Leo Rasche, Francesco Maura, Paola Neri, Nizar J Bahlis
Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma. Nature medicine (2023)
Alexander Michael Leipold, Rudolf A Werner, Johannes Düll, Pius Jung, Mara John, Emilia Stanojkovska, Xiang Zhou, Hannah Hornburger, Anna Ruckdeschel, Oliver Dietrich, Fabian Imdahl, Tobias Krammer, Stefan Knop, Andreas Rosenwald, Andreas Buck, Leif Erik Sander, Hermann Einsele, Klaus Martin Kortüm, Antoine-Emmanuel Saliba, Leo Rasche
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma. Leukemia 37 (3) (2023)
Alexander Michael Leipold, Rudolf A Werner, Johannes Düll, Pius Jung, Mara John, Emilia Stanojkovska, Xiang Zhou, Hannah Hornburger, Anna Ruckdeschel, Oliver Dietrich, Fabian Imdahl, Tobias Krammer, Stefan Knop, Andreas Rosenwald, Andreas Buck, Leif Erik Sander, Hermann Einsele, Klaus Martin Kortüm, Antoine-Emmanuel Saliba, Leo Rasche
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma. Leukemia 37 (3) (2023)
Larissa Haertle, Natalia Buenache, Hipólito Nicolás Cuesta Hernández, Michal Simicek, Renata Snaurova, Inmaculada Rapado, Nerea Martinez, Nieves López-Muñoz, José María Sánchez-Pina, Umair Munawar, Seungbin Han, Yanira Ruiz-Heredia, Rafael Colmenares, Miguel Gallardo, Margarita Sánchez-Beato, Miguel Angel Piris, Mehmet Kemal Samur, Nikhil C Munshi, Rosa María Ayala, Klaus Martin Kortüm, Santiago Barrio, Joaquin Martinez Lopez
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase ( PSMC ) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma. Cancers 15 (2) (2023)
Alexander Michael Leipold, Rudolf A Werner, Johannes Düll, Pius Jung, Mara John, Emilia Stanojkovska, Xiang Zhou, Hannah Hornburger, Anna Ruckdeschel, Oliver Dietrich, Fabian Imdahl, Tobias Krammer, Stefan Knop, Andreas Rosenwald, Andreas Buck, Leif Erik Sander, Hermann Einsele, Klaus Martin Kortüm, Antoine-Emmanuel Saliba, Leo Rasche
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma. Leukemia 37 (3) (2023)
Umair Munawar, Xiang Zhou, Sabrina Prommersberger, Silvia Nerreter, Cornelia Vogt, Maximilian Johannes Steinhardt, Marietta Truger, Julia Mersi, Eva Teufel, Seungbin Han, Larissa Haertle, Nicole Banholzer, Patrick Eiring, Sophia Danhof, Miguel Angel Navarro-Aguadero, Adrian Fernandez-Martin, Alejandra Ortiz-Ruiz, Santiago Barrio, Miguel Gallardo, Antonio Valeri, Eva Castellano, Peter Raab, Maximilian Rudert, Claudia Haferlach, Markus Sauer, Michael Hudecek, J Martinez-Lopez, Johannes Waldschmidt, Hermann Einsele, Leo Rasche, Klaus Martin Kortüm
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma. Communications biology 6 (1) (2023)
Alexander Michael Leipold, Rudolf A Werner, Johannes Düll, Pius Jung, Mara John, Emilia Stanojkovska, Xiang Zhou, Hannah Hornburger, Anna Ruckdeschel, Oliver Dietrich, Fabian Imdahl, Tobias Krammer, Stefan Knop, Andreas Rosenwald, Andreas Buck, Leif Erik Sander, Hermann Einsele, Klaus Martin Kortüm, Antoine-Emmanuel Saliba, Leo Rasche
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma. Leukemia (2023)
Umair Munawar, Xiang Zhou, Sabrina Prommersberger, Silvia Nerreter, Cornelia Vogt, Maximilian Johannes Steinhardt, Marietta Truger, Julia Mersi, Eva Teufel, Seungbin Han, Larissa Haertle, Nicole Banholzer, Patrick Eiring, Sophia Danhof, Miguel Angel Navarro-Aguadero, Adrian Fernandez-Martin, Alejandra Ortiz-Ruiz, Santiago Barrio, Miguel Gallardo, Antonio Valeri, Eva Castellano, Peter Raab, Maximilian Rudert, Claudia Haferlach, Markus Sauer, Michael Hudecek, J Martinez-Lopez, Johannes Waldschmidt, Hermann Einsele, Leo Rasche, Klaus Martin Kortüm
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma. Communications biology 6 (1) (2023)
Alexander Michael Leipold, Rudolf A Werner, Johannes Düll, Pius Jung, Mara John, Emilia Stanojkovska, Xiang Zhou, Hannah Hornburger, Anna Ruckdeschel, Oliver Dietrich, Fabian Imdahl, Tobias Krammer, Stefan Knop, Andreas Rosenwald, Andreas Buck, Leif Erik Sander, Hermann Einsele, Klaus Martin Kortüm, Antoine-Emmanuel Saliba, Leo Rasche
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma. Leukemia (2023)
Umair Munawar, Xiang Zhou, Sabrina Prommersberger, Silvia Nerreter, Cornelia Vogt, Maximilian Johannes Steinhardt, Marietta Truger, Julia Mersi, Eva Teufel, Seungbin Han, Larissa Haertle, Nicole Banholzer, Patrick Eiring, Sophia Danhof, Miguel Angel Navarro-Aguadero, Adrian Fernandez-Martin, Alejandra Ortiz-Ruiz, Santiago Barrio, Miguel Gallardo, Antonio Valeri, Eva Castellano, Peter Raab, Maximilian Rudert, Claudia Haferlach, Markus Sauer, Michael Hudecek, J Martinez-Lopez, Johannes Waldschmidt, Hermann Einsele, Leo Rasche, Klaus Martin Kortüm
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma. Communications biology 6 (1) (2023)
Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M Poos, Britta Besemer, Kaya Miah, Axel Benner, Nicole Becker, Thomas Moehler, Ivana Metzler, Cyrus Khandanpour, Andrea Seidel-Glaetzer, Karolin Trautmann-Grill, Klaus Martin Kortüm, Carsten Muller-Tidow, Gunhild Mechtersheimer, Benjamin Goeppert, Albrecht Stenzinger, Niels Weinhold, Hartmut Goldschmidt, Katja C Weisel, Marc S Raab
A phase II clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma. Blood (2023)
Umair Munawar, Xiang Zhou, Sabrina Prommersberger, Silvia Nerreter, Cornelia Vogt, Maximilian Johannes Steinhardt, Marietta Truger, Julia Mersi, Eva Teufel, Seungbin Han, Larissa Haertle, Nicole Banholzer, Patrick Eiring, Sophia Danhof, Miguel Angel Navarro-Aguadero, Adrian Fernandez-Martin, Alejandra Ortiz-Ruiz, Santiago Barrio, Miguel Gallardo, Antonio Valeri, Eva Castellano, Peter Raab, Maximilian Rudert, Claudia Haferlach, Markus Sauer, Michael Hudecek, J Martinez-Lopez, Johannes Waldschmidt, Hermann Einsele, Leo Rasche, Klaus Martin Kortüm
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma. Communications biology 6 (1) (2023)
Alexander Michael Leipold, Rudolf A Werner, Johannes Düll, Pius Jung, Mara John, Emilia Stanojkovska, Xiang Zhou, Hannah Hornburger, Anna Ruckdeschel, Oliver Dietrich, Fabian Imdahl, Tobias Krammer, Stefan Knop, Andreas Rosenwald, Andreas Buck, Leif Erik Sander, Hermann Einsele, Klaus Martin Kortüm, Antoine-Emmanuel Saliba, Leo Rasche
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma. Leukemia 37 (3) (2023)
Larissa Haertle, Natalia Buenache, Hipólito Nicolás Cuesta Hernández, Michal Simicek, Renata Snaurova, Inmaculada Rapado, Nerea Martinez, Nieves López-Muñoz, José María Sánchez-Pina, Umair Munawar, Seungbin Han, Yanira Ruiz-Heredia, Rafael Colmenares, Miguel Gallardo, Margarita Sánchez-Beato, Miguel Angel Piris, Mehmet Kemal Samur, Nikhil C Munshi, Rosa María Ayala, Klaus Martin Kortüm, Santiago Barrio, Joaquin Martinez Lopez
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase ( PSMC ) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma. Cancers 15 (2) (2023)
Umair Munawar, Xiang Zhou, Sabrina Prommersberger, Silvia Nerreter, Cornelia Vogt, Maximilian Johannes Steinhardt, Marietta Truger, Julia Mersi, Eva Teufel, Seungbin Han, Larissa Haertle, Nicole Banholzer, Patrick Eiring, Sophia Danhof, Miguel Angel Navarro-Aguadero, Adrian Fernandez-Martin, Alejandra Ortiz-Ruiz, Santiago Barrio, Miguel Gallardo, Antonio Valeri, Eva Castellano, Peter Raab, Maximilian Rudert, Claudia Haferlach, Markus Sauer, Michael Hudecek, J Martinez-Lopez, Johannes Waldschmidt, Hermann Einsele, Leo Rasche, Klaus Martin Kortüm
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma. Communications biology 6 (1) (2023)
David Böckle, Paula Tabares, Xiang Zhou, Sven Schimanski, Maximilian J Steinhardt, Max Bittrich, Elena Seebacher, Maria Ulbrich, Amy Wilnit, Corona Metz, Anke Heidemeier, Thorsten Bley, Rudolf Werner, Andreas Buck, Hermann Einsele, Klaus Martin Kortüm, Andreas Beilhack, Leo Rasche
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma. British journal of haematology 198 (3) (2022)
Anna Bögelein, Antje Stolzenburg, Patrick Eiring, Katharina Lückerath, Umair Munawar, Rudolf Werner, Andreas Schirbel, Samuel Samnick, Klaus Martin Kortüm, Markus Sauer, Constantin Lapa, Andreas K Buck
CXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents. Leukemia & lymphoma 63 (10) (2022)
Larissa Haertle, Santiago Barrio, Umair Munawar, Seungbin Han, Xiang Zhou, Michal Simicek, Cornelia Vogt, Marietta Truger, Rafael Alonso Fernández, Maximilian Johannes Steinhardt, Julia Weingart, Renata Snaurova, Silvia Nerreter, Eva Teufel, Andoni Garitano-Trojaola, Matteo Claudio Da Via, Yanira Ruiz-Heredia, Andreas Rosenwald, Niccolo' Bolli, Roman Hájek, Peter Raab, Marc-Steffen Raab, Niels Weinhold, Claudia Haferlach, Thomas Haaf, Joaquin Martinez Lopez, Hermann Einsele, Leo Rasche, Klaus Martin Kortüm
Single Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Maximilian Johannes Steinhardt, Xiang Zhou, Franziska Krummenast, Katharina Meckel, Katharina Nickel, David Böckle, Janin Messerschmidt, Sebastian Knorz, Alexander Dierks, Anke Heidemeier, Constantin Lapa, Hermann Einsele, Leo Rasche, Klaus Martin Kortüm
Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma. International journal of immunopathology and pharmacology 34 (2021)
Larissa Haertle, Santiago Barrio, Umair Munawar, Seungbin Han, Xiang Zhou, Cornelia Vogt, Rafael Alonso Fernández, Markus Krebs, Yanira Ruiz-Heredia, Matteo Claudio Da Via, Josip Zovko, Andoni Garitano-Trojaola, Niccolò Bolli, Anna Ruckdeschel, Thorsten Stühmer, Manik Chatterjee, Miriam Kull, Jan Krönke, Xabier Agirre, Jose I Martin-Subero, Peter Raab, Hermann Einsele, Leo Rasche, Joaquin Martinez-Lopez, Thomas Haaf, Klaus Martin Kortüm
Cereblon enhancer methylation and IMiD resistance in multiple myeloma. Blood 138 (18) (2021)
Julia Dahlhoff, Hannah Manz, Tim Steinfatt, Julia Delgado-Tascon, Elena Seebacher, Theresa Schneider, Amy Wilnit, Zeinab Mokhtari, Paula Tabares, David Böckle, Leo Rasche, Klaus Martin Kortüm, Manfred B Lutz, Hermann Einsele, Andreas Brandl, Andreas Beilhack
Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression. Leukemia (2021)
Matteo C Da Vià, Oliver Dietrich, Marietta Truger, Panagiota Arampatzi, Johannes Duell, Anke Heidemeier, Xiang Zhou, Sophia Danhof, Sabrina Kraus, Manik Chatterjee, Manja Meggendorfer, Sven Twardziok, Maria-Elisabeth Goebeler, Max S Topp, Michael Hudecek, Sabrina Rebecca Prommersberger, Kristen Hege, Shari Kaiser, Viktoria Fuhr, Niels Weinhold, Andreas Rosenwald, Florian Erhard, Claudia Haferlach, Hermann Einsele, Klaus Martin Kortüm, Antoine-Emmanuel Saliba, Leo Rasche
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma. Nature medicine 27 (4) (2021)
Marietta S Truger, Johannes Duell, Xiang Zhou, Larissa Heimeshoff, Anna Ruckdeschel, Mara John, Angela Riedel, Sebastian Hüper, Jessica Peter, Wencke Walter, Larissa Haertle, Manja Meggendorfer, Max S Topp, Andreas Rosenwald, Matteo Claudio Da Via, Niccolo Bolli, Niels Weinhold, Hermann Einsele, Claudia Haferlach, Klaus Martin Kortüm, Leo Rasche
Single- and double-hit events in genes encoding immune targets before and after T cell-engaging antibody therapy in MM. Blood advances 5 (19) (2021)
Sabrina Kraus, Alexander Dierks, Leo Rasche, Olivia Kertels, Malte Kircher, Andreas Schirbel, Josip Zovko, Torsten Steinbrunn, Raoul Tibes, Hans-Jürgen Wester, Andreas K Buck, Hermann Einsele, Klaus Martin Kortüm, Andreas Rosenwald, Constantin Lapa
68Ga-Pentixafor-PET/CT imaging represents a novel approach to detect chemokine receptor CXCR4 expression in myeloproliferative neoplasms. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2021)
Andoni Garitano-Trojaola, Ana Sancho, Ralph Götz, Patrick Eiring, Susanne Walz, Hardikkumar Jetani, Jesus Gil-Pulido, Matteo Claudio Da Via, Eva Teufel, Nadine Rhodes, Larissa Haertle, Estibaliz Arellano-Viera, Raoul Tibes, Andreas Rosenwald, Leo Rasche, Michael Hudecek, Markus Sauer, Juergen Groll, Hermann Einsele, Sabrina Kraus, Klaus Martin Kortüm
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia. Communications biology 4 (1) (2021)
Maria I Morales-Lozano, Oliver Viering, Samuel Samnick, Paula Rodriguez-Otero, Andreas K Buck, Maria Marcos-Jubilar, Leo Rasche, Elena Prieto, Klaus Martin Kortüm, Jesus San-Miguel, María José García-Velloso, Constantin Lapa
18F-FDG and 11C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers. Cancers 12 (4) (2020)
Xiang Zhou, Alexander Dierks, Olivia Kertels, Malte Kircher, Andreas Schirbel, Samuel Samnick, Andreas K Buck, Sebastian Knorz, David Böckle, Lukas Scheller, Janin Messerschmidt, Mohammad Barakat, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Constantin Lapa
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features. Cancers 12 (8) (2020)
Xiang Zhou, Alexander Dierks, Olivia Kertels, Samuel Samnick, Malte Kircher, Andreas K Buck, Larissa Haertle, Sebastian Knorz, David Böckle, Lukas Scheller, Janin Messerschmidt, Mohammad Barakat, Marietta Truger, Claudia Haferlach, Hermann Einsele, Leo Rasche, Klaus Martin Kortüm, Constantin Lapa
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CT. Cancers 12 (9) (2020)
Xiang Zhou, Patricia Flüchter, Katharina Nickel, Katharina Meckel, Janin Messerschmidt, David Böckle, Sebastian Knorz, Maximilian Johannes Steinhardt, Franziska Krummenast, Sophia Danhof, Hermann Einsele, Klaus Martin Kortüm, Leo Rasche
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease. Cancers 12 (4) (2020)
Sarah Goldman-Mazur, Artur Jurczyszyn, Jorge J Castillo, Anna Waszczuk-Gajda, Norbert Grząśko, Jakub Radocha, Max Bittrich, Klaus Martin Kortüm, Alessandro Gozzetti, Lidia Usnarska-Zubkiewicz, Julio D Valls, David S Jayabalan, Ruben Niesvizky, Julia Kelman, Daniel Coriu, Laura Rosinol, Łukasz Szukalski, Veronica González-Calle, Maria-Victoria Mateos-Manteca, Krzysztof Jamroziak, Iwona Hus, Irit Avivi, Yael C Cohen, Piotr K Mazur, Anna Suska, Aimee Chappell, Deepu Madduri, Saurabh Chhabra, Ariel Kleman, Parameswaran Hari, Michel Delforge, Paweł Robak, Massimo Gentile, Izabela Kozłowska, Stuart L Goldberg, Jacek Czepiel, Monika Długosz-Danecka, Rebecca Silbermann, Adam J Olszewski, Peter Barth, Gabor Mikala, Chor-Sang Chim, David H Vesole
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients. Leukemia & lymphoma 61 (8) (2020)
Matteo Claudio Da Via, Antonio Giovanni Solimando, Andoni Garitano-Trojaola, Santiago Barrio, Umair Munawar, Susanne Strifler, Larissa Haertle, Nadine Rhodes, Eva Teufel, Cornelia Vogt, Constantin Lapa, Andreas Beilhack, Leo Rasche, Hermann Einsele, Klaus Martin Kortüm
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement. The oncologist 25 (2) (2019)
Umair Munawar, Markus Roth, Santiago Barrio, Harald Wajant, Daniela Siegmund, Ralf C Bargou, Klaus Martin Kortüm, Thorsten Stühmer
Assessment of TP53 lesions for p53 system functionality and drug resistance in multiple myeloma using an isogenic cell line model. Scientific reports 9 (1) (2019)
Leo Rasche, Klaus Martin Kortüm, Marc S Raab, Niels Weinhold
The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma. International journal of molecular sciences 20 (5) (2019)
Patrick-Pascal Strunz, Marc Schmalzing, Anke Heidemeier, Leo Rasche, Hermann Einsele, Klaus Martin Kortüm
Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor. Leukemia & lymphoma 60 (14) (2019)

Klaus Martin Kortüm.css-eqlu8i{font-size:small;padding-left:4px;} (Martin Kortüm, K M Kortuem, K Martin Kortüm, K Martin Kortüm, Martin K Kortüm)

Publication Activity (10 Years)

Top Topics

Top Venues

Klaus Martin Kortüm (Martin Kortüm, K M Kortuem, K Martin Kortüm, K Martin Kortüm, Martin K Kortüm)